- Home
- CR vs LNTH Comparison
CR vs LNTH Comparison
Compare CR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- LNTH
- Stock Information
- Founded
- CR 1855
- LNTH 1956
- Country
- CR United States
- LNTH United States
- Employees
- CR N/A
- LNTH N/A
- Industry
- CR Metal Fabrications
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CR Industrials
- LNTH Health Care
- Exchange
- CR Nasdaq
- LNTH Nasdaq
- Market Cap
- CR 8.9B
- LNTH 7.5B
- IPO Year
- CR N/A
- LNTH 2015
- Fundamental
- Price
- CR $160.53
- LNTH $100.01
- Analyst Decision
- CR Strong Buy
- LNTH Strong Buy
- Analyst Count
- CR 6
- LNTH 6
- Target Price
- CR $174.80
- LNTH $129.83
- AVG Volume (30 Days)
- CR 370.1K
- LNTH 1.0M
- Earning Date
- CR 04-21-2025
- LNTH 05-01-2025
- Dividend Yield
- CR 0.57%
- LNTH N/A
- EPS Growth
- CR 13.55
- LNTH N/A
- EPS
- CR 5.05
- LNTH 4.36
- Revenue
- CR $2,131,200,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- CR $9.28
- LNTH $6.59
- Revenue Next Year
- CR $6.57
- LNTH $11.80
- P/E Ratio
- CR $31.66
- LNTH $22.88
- Revenue Growth
- CR 14.45
- LNTH 18.32
- 52 Week Low
- CR $128.50
- LNTH $57.92
- 52 Week High
- CR $188.52
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CR 53.89
- LNTH 54.30
- Support Level
- CR $150.41
- LNTH $94.80
- Resistance Level
- CR $155.32
- LNTH $100.20
- Average True Range (ATR)
- CR 4.36
- LNTH 4.52
- MACD
- CR 0.87
- LNTH -0.56
- Stochastic Oscillator
- CR 91.07
- LNTH 29.35
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.